233 related articles for article (PubMed ID: 11070167)
41. Acute EBV infection masquerading as "In-situ Follicular Lymphoma": a pitfall in the differential diagnosis of this entity.
Gru AA; Kreisel F; Duncavage E; Nguyen TT; Hassan A; Frater JL
Diagn Pathol; 2013 Jun; 8():100. PubMed ID: 23782909
[TBL] [Abstract][Full Text] [Related]
42. IgH and TcR-gamma gene rearrangements identified in Hodgkin's disease by PCR demonstrate lack of correlation between genotype, phenotype, and Epstein-Barr virus status.
Al Saati T; Galoin S; Gravel S; Lamant L; Roda D; Chittal SM; Delsol G
J Pathol; 1997 Apr; 181(4):387-93. PubMed ID: 9196435
[TBL] [Abstract][Full Text] [Related]
43. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
[TBL] [Abstract][Full Text] [Related]
44. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection.
de Leval L; Vivario M; De Prijck B; Zhou Y; Boniver J; Harris NL; Isaacson P; Du MQ
Am J Surg Pathol; 2004 May; 28(5):679-86. PubMed ID: 15105659
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang JS; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
N Engl J Med; 2003 Oct; 349(14):1324-32. PubMed ID: 14523140
[TBL] [Abstract][Full Text] [Related]
46. Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infection.
Al-Homsi AS; Berger C; van Baarle D; Kersten MJ; Klein MR; McQuain C; van Oers R; Knecht H
Int J Mol Med; 1998 Jun; 1(6):983-7. PubMed ID: 9852635
[TBL] [Abstract][Full Text] [Related]
47. [Detection of Epstein-Barr virus in the tonsils in infectious mononucleosis].
Sauerbrei A; Färber I; Wutzler P; Swoboda R; Schneider J
Laryngorhinootologie; 1990 Feb; 69(2):70-3. PubMed ID: 2157451
[TBL] [Abstract][Full Text] [Related]
48. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.
Carbone A; Gloghini A; Caruso A; De Paoli P; Dolcetti R
Int J Cancer; 2017 Mar; 140(6):1233-1245. PubMed ID: 27750386
[TBL] [Abstract][Full Text] [Related]
49. Infectious mononucleosis and Epstein-Barr virus.
Vetsika EK; Callan M
Expert Rev Mol Med; 2004 Nov; 6(23):1-16. PubMed ID: 15541197
[TBL] [Abstract][Full Text] [Related]
50. Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization.
Niedobitek G; Hamilton-Dutoit S; Herbst H; Finn T; Vetner M; Pallesen G; Stein H
Hum Pathol; 1989 Aug; 20(8):796-9. PubMed ID: 2545594
[TBL] [Abstract][Full Text] [Related]
51. Pediatric epstein-barr virus carriers with or without tonsillar enlargement may substantially contribute to spreading of the virus.
Hug M; Dorner M; Fröhlich FZ; Gysin C; Neuhaus D; Nadal D; Berger C
J Infect Dis; 2010 Oct; 202(8):1192-9. PubMed ID: 20815705
[TBL] [Abstract][Full Text] [Related]
52. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype.
Maini MK; Gudgeon N; Wedderburn LR; Rickinson AB; Beverley PC
J Immunol; 2000 Nov; 165(10):5729-37. PubMed ID: 11067931
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
[TBL] [Abstract][Full Text] [Related]
54. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease.
Khan G; Naase MA
J Clin Pathol; 1995 Sep; 48(9):845-8. PubMed ID: 7490319
[TBL] [Abstract][Full Text] [Related]
55. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion.
Ohshima K; Muta K; Nakashima M; Haraoka S; Tutiya T; Suzumiya J; Kawasaki C; Watanabe T; Kikuchi M
Int J Cancer; 2001 Jul; 93(1):91-6. PubMed ID: 11391627
[TBL] [Abstract][Full Text] [Related]
56. [Study of clinical and morphological features, immunophenotype and Epstein-Bar virus infection in situ of infectious mononucleosis].
Chen YZ; Zhou XG; Jin Y; Zheng YY; Chen G; Shi Y
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):440-4. PubMed ID: 19035113
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus in Hodgkin's disease.
Herbst H
Semin Cancer Biol; 1996 Aug; 7(4):183-9. PubMed ID: 8946602
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients.
Chaganti S; Ma CS; Bell AI; Croom-Carter D; Hislop AD; Tangye SG; Rickinson AB
Blood; 2008 Aug; 112(3):672-9. PubMed ID: 18509091
[TBL] [Abstract][Full Text] [Related]
59. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.
Minamitani T; Ma Y; Zhou H; Kida H; Tsai CY; Obana M; Okuzaki D; Fujio Y; Kumanogoh A; Zhao B; Kikutani H; Kieff E; Gewurz BE; Yasui T
Proc Natl Acad Sci U S A; 2017 May; 114(18):4751-4756. PubMed ID: 28351978
[TBL] [Abstract][Full Text] [Related]
60. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.
Babcock GJ; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12250-5. PubMed ID: 11035774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]